Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Prevalence of Germline Pathogenic RET Variants in a Pan-Cancer Patient Population.
Journal: JCO precision oncology
Published: May 22, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.
Journal: Cancer cell
Published: April 19, 2026
Preventive vaccines for hereditary cancer syndromes.
Journal: Nature medicine
Published: February 26, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases.
Journal: JCO precision oncology
Published: January 29, 2026
Comprehensive clinical and genomic analysis of early onset cancer of the bladder and upper urinary tract.
Journal: Journal of the National Cancer Institute
Published: December 22, 2025
PTCH1 mutations and tumor-agnostic clinical outcomes with hedgehog pathway inhibitors across cancer types.
Journal: NPJ precision oncology
Published: November 03, 2025
Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 25, 2025
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study.
Journal: Nature communications
Published: July 28, 2025
Subclinical Telomere Biology Disorder in Cancer Patients Heterozygous for the RTEL1 R1264H Founder Variant.
Journal: American journal of medical genetics. Part A
Published: June 30, 2025
Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
Journal: Gynecologic oncology
Published: April 17, 2025
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum.
Journal: NPJ precision oncology
Published: April 02, 2025
Last Updated: 09/26/2026